Although data from two conflicting reports do not suggest the pro-tumorigenic role of DUSP9 in TNBC, DUSP9 regulates the ERK pathway in TNBC and plays a role in chemotherapeutic resistance and cancer stemness of TNBC cells (Table 2, Figure 3). This evidence concerns the gene MAPK1 and cancer.